• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
dollars money ocean dollar bill
Biotech

LB Pharmaceuticals eyes $228M in IPO cash

The CNS-focused company is looking to pull off the first biotech IPO since February and collect $228.5 million in much-needed funding.
Zoey Becker Sep 8, 2025 3:16pm
BioNTech

BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC

Sep 8, 2025 11:00am
Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects another ultra-rare disease prospect

Sep 8, 2025 10:59am
Microbot Liberty

FDA clears Microbot’s remote-controlled cath lab system

Sep 8, 2025 11:45am
Cat

Regeneron antibodies post ph. 3 wins against cat, pollen allergy

Sep 8, 2025 9:54am
White arrow on a road pointing to the rising sun

Dianthus' gMG asset blooms as phase 2 win sets up pivotal plans

Sep 8, 2025 9:24am
More News

Atom claims ph. 3 win shows gout drug can beat competition

Sep 8, 2025 9:01am

Rapport's seizure drug hits in phase 2, sending stock soaring

Sep 8, 2025 8:25am

Fierce Biotech Fundraising Tracker: NRG Tx, Epigenic & more

Sep 8, 2025 8:20am

Takeda, Alkermes lift lid on narcolepsy rivals as race heats up

Sep 8, 2025 6:47am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings